Nabriva Therapeutics (NBRVF) Q1 2022 Earnings

5MayExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-0.35
-0.29
-0.24
-0.19

Details

Expected EPS
-0.19
Actual EPS
-0.2
Surprise EPS
-0.01
Surprise Percent
+5.26%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.2 per share for Q1 2022.

0 Comments

Share your thoughts